Blood Cancer Therapeutics Laboratory


2018 Blood Cancer Therapeutics group L-R: A/Prof Jake Shortt, Dr Jonathan Wong, Dr Zahra Sabouri-Thompson, Dr Gareth Gregory, Ms Belinda Maher, Dr Daniella Brasacchio, Dr Mark Waltham, Ms Maria Docanto, Dr Greg Corboy, Dr Danielle Oh, Dr Josh Casan

Donate to research in the
Blood Cancer Therapeutics Lab

Blood Cancer Therapeutics Laboratory

Our research seeks to evaluate novel ways to treat haematological malignancies, with a particular focus on lymphoma and multiple myeloma. By determining the molecular mechanisms underpinning specific blood cancers, we are developing novel therapeutic strategies for translation into clinical trials.  Our location within the Monash Health Translation Precinct uniquely places the laboratory in a position to develop our scientific discoveries from bench to bedside.

Major themes include, oncogenic transcription, epigenetic therapy for lymphoma and myeloma, lymphoma genomics and rational targeting of the MYC oncogene.